MENU

OTLK Outlook Therapeutics Forecast, Technical & Fundamental Analysis

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications... Show more

Industry: #Biotechnology
OTLK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
OTLK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of biosimilar versions of biopharmaceuticals

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
111 S. Wood Avenue
Phone
+1 609 619-3990
Employees
17
Web
https://www.outlooktherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GDIIX25.79N/A
N/A
Genter Dividend Income
ARBNX14.29N/A
N/A
Arbitrage I
QAMNX21.57N/A
N/A
Federated Hermes MDT Market Neutral A
JMVZX30.47N/A
N/A
JPMorgan Mid Cap Value R2
SSDIX44.77N/A
N/A
DWS Small Cap Growth Inst

OTLK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OTLK has been loosely correlated with GNPX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if OTLK jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
-1.27%
GNPX - OTLK
38%
Loosely correlated
-4.41%
APVO - OTLK
37%
Loosely correlated
+5.33%
CANF - OTLK
34%
Loosely correlated
+0.31%
CYTK - OTLK
33%
Loosely correlated
-3.10%
PDSB - OTLK
33%
Loosely correlated
-3.71%
More
Outlook Therapeutics (OTLK) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com